HomeBOLT • NASDAQ
Bolt Biotherapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.80M | 41.49% |
Operating expense | 3.52M | -27.86% |
Net income | -8.56M | 59.61% |
Net profit margin | -474.56 | 71.45% |
Earnings per share | -4.46 | 60.18% |
EBITDA | -8.86M | 52.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.77M | -52.82% |
Total assets | 75.50M | -39.20% |
Total liabilities | 36.66M | -4.33% |
Total equity | 38.84M | — |
Shares outstanding | 1.92M | — |
Price to book | 0.26 | — |
Return on assets | -28.54% | — |
Return on capital | -34.23% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -8.56M | 59.61% |
Cash from operations | -9.60M | 40.55% |
Cash from investing | 10.79M | -40.05% |
Cash from financing | 14.00K | -82.28% |
Net change in cash | 1.21M | -37.63% |
Free cash flow | -6.09M | 10.07% |
Previous close
$5.31
Day range
$5.31 - $5.49
Year range
$4.59 - $14.28
Market cap
10.25M USD
Avg Volume
12.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
52
